A Brief Outline of Infectious Diseases of Olive

Author(s):  
Giovanni P. Martelli

Abstract: Virus infections of olive (Olea europaea), to which littte attention has been paid up to a relatively recent past, are surprisingly widespread, as shown by: (i) the very high presence (above 50% in average) of double-stranded ribonucleic acids (dsRNAs) in the plants analysed in the course of field surveys carried out especially in the Mediterranean and Middle Eastern countries; (ii) the identification in these plants of 15 different viruses with diverse taxonomic allocation. Infections are generally symptomless. When shown, symptoms consist of deformations of fruits and leaves and of foliar discolourations ranging from chlorosis to bright yellowing. “Bumpy fruits” and the “Leaf yellowing complex” are the only two diseases whose viral aetiology seems to be convincingly ascertained. Virus identification is not based on biotests (mechanical transmission to herbaceous hosts is unreliable and there are no differential woody indicators available) nor on immunoenzymatic assays (ELISA), which are also unreliable, but on nucleic acid-based techniques (various RT-PCR protocols). The economic impact of infections has not been determined although recent reports indicate that some viruses seem to affect the yield and the quality of the oil. For an ultimate answer, a comparison needs to be done between selected and sanitazied accessions and their infected counterparts. Equally scanty is the information on the epidemiology of olive-infecting viruses, except for three necroviruses (OLV-1, TNV-D and OMMV), whose transmission through soil, direct or mediated by Olpidium brassicae, has been experimentally ascertained. Olive latent virus 1 (OLV-1) and Cherry leafroll virus (CLRV) are transmitted through seeds and seedlings and, like all the other viruses, with propagating material (nursery productions), which is the major responsible for their worldwide distribution. Viral infections have been detected in 22 countries in the five continents. Preventive control through certification schemes is desirable. One of such schemes designed and implemented in Italy, is based on the pomological and sanitary selection and sanitation of mother stocks.

Author(s):  
Giovanni P. Martelli

Abstract: Virus infections of olive (Olea europaea), to which littte attention has been paid up to a relatively recent past, are surprisingly widespread, as shown by: (i) the very high presence (above 50% in average) of double-stranded ribonucleic acids (dsRNAs) in the plants analysed in the course of field surveys carried out especially in the Mediterranean and Middle Eastern countries; (ii) the identification in these plants of 15 different viruses with diverse taxonomic allocation. Infections are generally symptomless. When shown, symptoms consist of deformations of fruits and leaves and of foliar discolourations ranging from chlorosis to bright yellowing. “Bumpy fruits” and the “Leaf yellowing complex” are the only two diseases whose viral aetiology seems to be convincingly ascertained. Virus identification is not based on biotests (mechanical transmission to herbaceous hosts is unreliable and there are no differential woody indicators available) nor on immunoenzymatic assays (ELISA), which are also unreliable, but on nucleic acid-based techniques (various RT-PCR protocols). The economic impact of infections has not been determined although recent reports indicate that some viruses seem to affect the yield and the quality of the oil. For an ultimate answer, a comparison needs to be done between selected and sanitazied accessions and their infected counterparts. Equally scanty is the information on the epidemiology of olive-infecting viruses, except for three necroviruses (OLV-1, TNV-D and OMMV), whose transmission through soil, direct or mediated by Olpidium brassicae, has been experimentally ascertained. Olive latent virus 1 (OLV-1) and Cherry leafroll virus (CLRV) are transmitted through seeds and seedlings and, like all the other viruses, with propagating material (nursery productions), which is the major responsible for their worldwide distribution. Viral infections have been detected in 22 countries in the five continents. Preventive control through certification schemes is desirable. One of such schemes designed and implemented in Italy, is based on the pomological and sanitary selection and sanitation of mother stocks.


2020 ◽  
Vol 20 (4) ◽  
pp. 423-432 ◽  
Author(s):  
Imre Kovesdi ◽  
Tibor Bakacs

: Viral interference, originally, referred to a state of temporary immunity, is a state whereby infection with a virus limits replication or production of a second infecting virus. However, replication of a second virus could also be dominant over the first virus. In fact, dominance can alternate between the two viruses. Expression of type I interferon genes is many times upregulated in infected epithelial cells. Since the interferon system can control most, if not all, virus infections in the absence of adaptive immunity, it was proposed that viral induction of a nonspecific localized temporary state of immunity may provide a strategy to control viral infections. Clinical observations also support such a theory, which gave credence to the development of superinfection therapy (SIT). SIT is an innovative therapeutic approach where a non-pathogenic virus is used to infect patients harboring a pathogenic virus. : For the functional cure of persistent viral infections and for the development of broad- spectrum antivirals against emerging viruses a paradigm shift was recently proposed. Instead of the virus, the therapy should be directed at the host. Such a host-directed-therapy (HDT) strategy could be the activation of endogenous innate immune response via toll-like receptors (TLRs). Superinfection therapy is such a host-directed-therapy, which has been validated in patients infected with two completely different viruses, the hepatitis B (DNA), and hepatitis C (RNA) viruses. SIT exerts post-infection interference via the constant presence of an attenuated non-pathogenic avian double- stranded (ds) RNA viral vector which boosts the endogenous innate (IFN) response. SIT could, therefore, be developed into a biological platform for a new “one drug, multiple bugs” broad-spectrum antiviral treatment approach.


2021 ◽  
Vol 13 (3) ◽  
pp. 363-382
Author(s):  
Mario Dioguardi ◽  
Angela Pia Cazzolla ◽  
Claudia Arena ◽  
Diego Sovereto ◽  
Giorgia Apollonia Caloro ◽  
...  

COVID-19 (Coronavirus Disease 2019) is an emerging viral disease caused by the coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which leads to severe respiratory infections in humans. The first reports came in December 2019 from the city of Wuhan in the province of Hubei in China. It was immediately clear that children developed a milder disease than adults. The reasons for the milder course of the disease were attributed to several factors: innate immunity, difference in ACE2 (angiotensin-converting enzyme II) receptor expression, and previous infections with other common coronaviruses (CovH). This literature review aims to summarize aspects of innate immunity by focusing on the role of ACE2 expression and viral infections in children in modulating the antibody response to SARS-CoV-2 infection. This review was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Articles deemed potentially eligible were considered, including those dealing with COVID-19 in children and providing more up-to-date and significant data in terms of epidemiology, prognosis, course, and symptoms, focusing on the etiopathogenesis of SARS-CoV-2 disease in children. The bibliographic search was conducted using the search engines PubMed and Scopus. The following search terms were entered in PubMed and Scopus: COVID-19 AND ACE2 AND Children; COVID-19 AND Immunity innate AND children. The search identified 857 records, and 18 studies were applicable based on inclusion and exclusion criteria that addressed the issues of COVID-19 concerning the role of ACE2 expression in children. The scientific literature agrees that children develop milder COVID-19 disease than adults. Milder symptomatology could be attributed to innate immunity or previous CovH virus infections, while it is not yet fully understood how the differential expression of ACE2 in children could contribute to milder disease.


Virology ◽  
1987 ◽  
Vol 160 (1) ◽  
pp. 183-190 ◽  
Author(s):  
Fernando Ponz ◽  
Adib Rowhani ◽  
S.M. Mircetich ◽  
George Bruening

2015 ◽  
Vol 4 (3) ◽  
Author(s):  
Giuseppina Tantillo ◽  
Marilisa Bottaro ◽  
Angela Di Pinto ◽  
Vito Martella ◽  
Pietro Di Pinto ◽  
...  

The health and vigour of honeybee colonies are threatened by numerous parasites (such as <em>Varroa destructor</em> and <em>Nosema</em> spp.) and pathogens, including viruses, bacteria, protozoa. Among honeybee pathogens, viruses are one of the major threats to the health and wellbeing of honeybees and cause serious concern for researchers and beekeepers. To tone down the threats posed by these invasive organisms, a better understanding of bee viral infections will be of crucial importance in developing effective and environmentally benign disease control strategies. Here we summarize recent progress in the understanding of the morphology, genome organization, transmission, epidemiology and pathogenesis of eight honeybee viruses: Deformed wing virus (DWV) and Kakugo virus (KV); Sacbrood virus (SBV); Black Queen cell virus (BQCV); Acute bee paralysis virus (ABPV); Kashmir bee virus (KBV); Israeli Acute Paralysis Virus (IAPV); Chronic bee paralysis virus (CBPV). The review has been designed to provide researchers in the field with updated information about honeybee viruses and to serve as a starting point for future research.


1987 ◽  
Vol 21 (5) ◽  
pp. 399-405 ◽  
Author(s):  
Milap C. Nahata

Remarkable progress has been made in antiviral chemotherapy. Six approved antiviral drugs are now available for the treatment of various viral infections. Trifluridine, idoxuridine and vidarabine are all effective in patients with herpes keratitis; trifluridine is preferred due to its low toxicity. Acyclovir is the drug of choice in patients with infections due to herpes simplex viruses, including genital herpes, herpes encephalitis, and neonatal herpes, and infections due to varicella-zoster virus. Amantadine is the only drug currently available for prophylaxis and treatment of influenza A, but an investigational drug, rimantadine, appears to be equally effective and less toxic than amantadine. Ribavirin is the most recently approved antiviral agent for the treatment of respiratory syncytial virus infections. Numerous antiviral drugs are being studied in patients with acquired immunodeficiency syndrome. Although currently available drugs have improved our ability to manage a variety of viral illnesses, much needs to be learned about specific dosage guidelines based on the studies of pharmacokinetics, pharmacodynamics, potential adverse effects and viral resistance, and the role of combination therapy to optimize therapy.


2021 ◽  
Vol 12 ◽  
Author(s):  
Miguel Ángel Palacios-Pedrero ◽  
Albert D. M. E. Osterhaus ◽  
Tanja Becker ◽  
Husni Elbahesh ◽  
Guus F. Rimmelzwaan ◽  
...  

Immunosenescence is a process associated with aging that leads to dysregulation of cells of innate and adaptive immunity, which may become dysfunctional. Consequently, older adults show increased severity of viral and bacterial infections and impaired responses to vaccinations. A better understanding of the process of immunosenescence will aid the development of novel strategies to boost the immune system in older adults. In this review, we focus on major alterations of the immune system triggered by aging, and address the effect of chronic viral infections, effectiveness of vaccination of older adults and strategies to improve immune function in this vulnerable age group.


2021 ◽  
Vol 12 ◽  
Author(s):  
Shuangjie Li ◽  
Jie Yang ◽  
Yuanyuan Zhu ◽  
Hui Wang ◽  
Xingyu Ji ◽  
...  

The RLRs play critical roles in sensing and fighting viral infections especially RNA virus infections. Despite the extensive studies on RLRs in humans and mice, there is a lack of systemic investigation of livestock animal RLRs. In this study, we characterized the porcine RLR members RIG-I, MDA5 and LGP2. Compared with their human counterparts, porcine RIG-I and MDA5 exhibited similar signaling activity to distinct dsRNA and viruses, via similar and cooperative recognitions. Porcine LGP2, without signaling activity, was found to positively regulate porcine RIG-I and MDA5 in transfected porcine alveolar macrophages (PAMs), gene knockout PAMs and PK-15 cells. Mechanistically, LGP2 interacts with RIG-I and MDA5 upon cell activation, and promotes the binding of dsRNA ligand by MDA5 as well as RIG-I. Accordingly, porcine LGP2 exerted broad antiviral functions. Intriguingly, we found that porcine LGP2 mutants with defects in ATPase and/or dsRNA binding present constitutive activity which are likely through RIG-I and MDA5. Our work provided significant insights into porcine innate immunity, species specificity and immune biology.


2016 ◽  
Vol 90 (9) ◽  
pp. 4258-4261 ◽  
Author(s):  
Matthew R. Hendricks ◽  
Jennifer M. Bomberger

Respiratory virus infections are common but generally self-limiting infections in healthy individuals. Although early clinical studies reported low detection rates, the development of molecular diagnostic techniques by PCR has led to an increased recognition that respiratory virus infections are associated with morbidity and acute exacerbations of chronic lung diseases, such as cystic fibrosis (CF). The airway epithelium is the first barrier encountered by respiratory viruses following inhalation and the primary site of respiratory viral replication. Here, we describe how the airway epithelial response to respiratory viral infections contributes to disease progression in patients with CF and other chronic lung diseases, including the role respiratory viral infections play in bacterial acquisition in the CF patient lung.


Author(s):  
Irina Shirokova ◽  
◽  
Yuliya Prozherina ◽  

The late 20th century and the early 21st century have been marked by the explosive development of virology due to activation of viral infections. New mutations of the influenza virus, high incidence of persistent virus infections in humans, as well as respiratory viral diseases that have not yet been eradicated has boosted further development of this direction [1].


Sign in / Sign up

Export Citation Format

Share Document